GBA
Gaucher Disease: GBA Sequencing
Key Information
Lab:
TAT:
21 days
Price:
$1,000
CPT Code(s):
81479
Test Code:
DGBA
Prenatal Samples Accepted
Gaucher Disease: GBA Sequencing
GBA sequencing is a molecular test used to identify variants in the gene associated with Gaucher disease. This test can also confirm a diagnosis and identify disease-causing variants within a family to facilitate carrier screening.
Gaucher disease
Clinical Information
Gaucher disease, a lysosomal storage disorder, can present with a wide spectrum of severity ranging from a perinatal lethal phenotype to asymptomatic. There are three primary types with two additional subtypes, all categorized by differences in the clinical presentation of the patient. Hepatosplenomegaly, pulmonary disease, and cytopenia are also common for most types of Gaucher disease.
Patients with Gaucher disease type 1 have varying degrees and types of bone disease as the primary feature, but do not have any central nervous system involvement. Gaucher disease types 2 and 3 present with primary neurologic disease. Type 2 and 3 are distinguished based on age of onset and disease progression. Patients with type 2 typically have an earlier onset before age 2, rapid disease progression, and early death. Type 3 is characterized by a slower disease course with patients living into adulthood. Neurologic findings for types 2 & 3 include bulbar signs, pyramidal signs, oculomotor apraxia, seizures, as well as dementia and ataxia in later disease stages. The perinatal lethal form may present as nonimmune hydrops fetalis or with pyramidal neurologic signs and ichthyosiform skin changes. The cardiovascular form is characterized by primarily by calcification of mitral and aortic values with other minor findings.
Technical Information
Specimen Requirements
Transport Instructions
Prenatal Testing Information
Prenatal diagnosis may be available for familial pathogenic or likely pathogenic variants; full sequencing of the GBA gene is not available. For variants identified at external laboratories, GGC will need to review the variant classification prior to sample receipt.
Prenatal diagnosis is not available for variants of uncertain clinical significance. Additional fees for cell culture and maternal cell contamination may apply. Maternal cell contamination studies are required for all prenatal molecular tests. Contact the laboratory prior to sending a prenatal specimen to confirm that targeted testing can be accepted.
Prenatal Specimen Requirements
Prenatal Transport Instructions
Associated Tests
Connect With Our Experts
Call 1-800-473-9411 to speak with our team of laboratory genetic counselors for questions or additional information.
Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC
